# Pneumococcal Conjugate Vaccine Followup

> **NCT01414504** · PHASE2 · COMPLETED · sponsor: **William Pomat** · enrollment: 280 (actual)

## Conditions studied

- Immune Tolerance

## Interventions

- **BIOLOGICAL:** Prevenar + PPV
- **BIOLOGICAL:** Infant PCV (Prevenar) + PPV at 9 months
- **BIOLOGICAL:** No Prevenar + PPV at 9 months
- **BIOLOGICAL:** Control

## Key facts

- **NCT ID:** NCT01414504
- **Lead sponsor:** William Pomat
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-09
- **Final completion:** 2012-09
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2012-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414504, "Pneumococcal Conjugate Vaccine Followup". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01414504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*